Assessment of the thioredoxin system as a new therapeutic target in B-cell acute lymphoblastic leukemia
Project Title
Ocena układu tioredoksyny jako nowego celu terapeutycznego w ostrej białaczce limfoblastycznej B komórkowej
Konkurs/program
ETIUDA 7
Financing Institution
Lead
mgr inż. Klaudyna Fidyt
Project Objective
The main aim of the study is to validate the thioredoxin system as a new therapeutic target in the treatment of B-ALL with the use of cell lines, material isolated from B-ALL patients, as well as with the use of mouse models.